Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Fiserv's Q3 Adjusted Earnings, Revenue Decline; 2026 Adjusted EPS Outlook Maintained

Fiserv's Q3 Adjusted Earnings, Revenue Decline; 2026 Adjusted EPS Outlook Maintained

MT newswireMT newswire2026/11/03 11:30
07:30 AM EST, 11/03/2026 (MT Newswires) -- Fiserv (FISV) reported Q3 adjusted earnings Tuesday of $1.75 per diluted share, down from $2.04 a year earlier. Analysts polled by FactSet expected $1.72. Revenue for the quarter ended Sept. 30 was $5.20 billion, compared with $5.26 billion a year earlier. Analysts expected $4.85 billion. The company reiterated its 2026 adjusted EPS outlook of $7.20 to $7.40. Analysts expect $7.24. In addition, Fiserv said it expects to resume share buybacks in Q4 with plans to repurchase $500 million in shares during the quarter. Fiserv shares were up more than 7% premarket Tuesday.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss